Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p34
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 34/66)
Character Range: 93376–96212

form Capsule 150 mg [Maximum Quantity: 10; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C5536 C5585  substitute: C16037 C16075
(b) omit from the column headed "Purposes": P5536 P5585 substitute: P16037 P16075
[240] Schedule 1, Part 1, entry for Rifampicin in the form Capsule 150 mg [Maximum Quantity: 100; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C5552 C11018  substitute: C15973 C16043
(b) omit from the column headed "Purposes": P5552 P11018 substitute: P15973 P16043
[241] Schedule 1, Part 1, entry for Rifampicin in the form Capsule 150 mg [Maximum Quantity: 120; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C11018  substitute: C16043
(b) omit from the column headed "Purposes": P11018 substitute: P16043

[242] Schedule 1, Part 1, entry for Rifampicin in the form Capsule 300 mg [Maximum Quantity: 10; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C5536 C5585  substitute: C16037 C16075
(b) omit from the column headed "Purposes": P5536 P5585 substitute: P16037 P16075
[243] Schedule 1, Part 1, entry for Rifampicin in the form Capsule 300 mg [Maximum Quantity: 100; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C5552 C11018  substitute: C15973 C16043
(b) omit from the column headed "Purposes": P5552 P11018 substitute: P15973 P16043
[244] Schedule 1, Part 1, entry for Rifampicin in the form Capsule 300 mg [Maximum Quantity: 120; Number of Repeats: 0]
(a) omit from the column headed "Circumstances": C11018  substitute: C16043
(b) omit from the column headed "Purposes": P11018 substitute: P16043
[245] Schedule 1, Part 1, entry for Rifampicin in the form Syrup 100 mg per 5 mL, 60 mL
omit from the column headed "Circumstances": C5536 C5585  substitute: C16037 C16075
[246] Schedule 1, Part 1, entries for Riluzole in the form Tablet 50 mg
omit:
Riluzole  Tablet 50 mg  Oral  APO-Riluzole  TX  MP NP  C5341 C8738  P5341 P8738  56   5     56
Riluzole  Tablet 50 mg  Oral  APO-Riluzole  TX  MP NP  C15719       P15719       112  5     56

[247] Schedule 1, Part 1, entry for Risperidone in the form Oral solution 1 mg per mL, 100 mL [Brand: Risperdal; Maximum Quantity: 1; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C6899
(b) insert in numerical order in the column headed "Circumstances": C16048
(c) omit from the column headed "Purposes": P6899
(d) insert in numerical order in the column headed "Purposes": P16048
[248] Schedule 1, Part 1, entry for Risperidone in the form Oral solution 1 mg per mL, 100 mL [Brand: Risperidone Lupin; Maximum Quantity: 1; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C6899
(b) insert in numerical order in the column headed "Circumstances": C16048
(c) omit from the column headed "Purposes": P6899
(d)